- Service Name
Ncardia
- Industry
Biotechnology, Drug Discovery, Cell Therapy, Regenerative Medicine
- Main Value Proposition
Ncardia empowers drug innovators to make confident decisions early in the therapeutic development process by providing integrated iPSC solutions.
- Description
Ncardia specializes in providing high-quality human induced pluripotent stem cells (iPSCs) and related services to support drug discovery and development. Their expertise enables therapeutic developers to enhance their pipelines with reliable cell models and screening assays.
- Key Features
High-quality iPSC products; Custom iPSC services for differentiation and expansion; Relevant screening assays for drug discovery; Expertise in regenerative medicine
- Use Cases
Drug discovery and development; Therapeutic candidate screening; Regenerative medicine applications; Custom iPSC differentiation processes
- Competitive advantages
Extensive experience with over 150 iPSC-based therapeutic projects supported; Strong partnerships with 17 of the top 20 global pharmaceutical companies; Comprehensive portfolio of relevant cell models and screening assays
- Strengths
Ncardia's main strengths include its pioneering role in iPSC technology, a robust portfolio of products and services, and a commitment to quality and customer satisfaction.
- Positioning
Ncardia positions itself as a trusted partner for therapeutic developers, focusing on enhancing the success of drug discovery through innovative iPSC solutions.
- Audience
The primary target users are drug developers, pharmaceutical companies, and researchers in the field of regenerative medicine and drug discovery.
- Brand Positioning
Ncardia's brand identity is built on expertise in iPSC technology, a commitment to quality, and a customer-centric approach, establishing it as a leader in the biotechnology sector.
- CTA
Start a conversation
- Differentiation
Ncardia stands out in the market by combining over 15 years of experience in iPSC technology with a strong focus on quality and customer service, ensuring that clients receive dependable and functional cell models.
- Tagline
Enabling Therapeutic Developers to Harness the Full Potential of iPSCs in their Pipelines
- Tags
iPSC technology
drug discovery
regenerative medicine
cell models
- Tone of Voice
Professional, supportive, innovative
- Founded
2010-01-01
- Founders
Stefan Braam